Evidence map›Paper›PMID 41226719›Full record

ArticleInternational journal of molecular sciences2025

Efficient Delivery of CRISPR-Cas9 RNP Complexes with Cyclodextrin-Based Nanosponges for Enhanced Genome Editing: TILD-CRISPR Integration.

Shahin Amiri, Setare Adibzadeh, Yousef Khazaei Monfared, Saeed Kaboli, Arash Arashkia, Farzaneh Barkhordari, Mohammad Mahmoudian, Mohammad Hassan Kheirandish, Francesco Trotta, Fatemeh Davami

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shahin AmiriDepartment of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran 13169-43511, Iran.ORCID 0000-0003-0596-2076
Setare AdibzadehDepartment of Nanoscale Science and Engineering, College of Nanotechnology, Science & Engineering University at Albany, State University of New York, Albany, NY 12222, USA.
Yousef Khazaei MonfaredDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.ORCID 0000-0002-1171-8670
Saeed KaboliDepartment of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan 45137-66371, Iran.ORCID 0000-0002-0335-9962
Arash ArashkiaDepartment of Molecular Virology, Pasteur Institute of Iran, Tehran 13169-43511, Iran.ORCID 0000-0002-3117-3217
Farzaneh BarkhordariDepartment of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran 13169-43511, Iran.
Mohammad MahmoudianCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.ORCID 0000-0003-4820-3942
Mohammad Hassan KheirandishDepartment of Medical Biotechnology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd 89151-73143, Iran.
Francesco TrottaDepartment of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy.
Fatemeh DavamiDepartment of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran 13169-43511, Iran.

Funding

Pasteur Institute of Iran BD-66002183
6 · The paper itself

Abstract

The CRISPR-Cas9 system has transformed biomedical research by enabling precise genetic modifications. However, efficient delivery of CRISPR components remains a major hurdle for therapeutic applications. To address this, we employed a new modified cationic hyper-branched cyclodextrin-based polymer (Ppoly) system to deliver an integrating GFP gene using the TILD-CRISPR method, which couples donor DNA linearization with RNP complexes. The physicochemical properties, loading efficiency, and cellular uptake of RNP with Ppoly were studied. After transfection, antibiotic selection and single-cell cloning were performed. Junction PCR was then performed on the isolated clones, and we compared the knock-in efficiency of Ppoly with that of the commercial CRISPRMAX™ reagent (Thermo Fisher, Invitrogen™, Waltham, MA, USA). The results demonstrate the encapsulation efficiency of over 90% for RNP and Ppoly, and cell viability remaining above 80%, reflecting the minimal toxicity of this approach. These attributes facilitated successful GFP gene integration using the TILD-CRISPR with RNP delivered via cyclodextrin-based nanosponges. The present method achieved a remarkable 50% integration efficiency in CHO-K1 cells, significantly outperforming the 14% observed with CRISPRMAX™ while maintaining lower cytotoxicity. This study highlights a promising platform for precise and efficient genome editing, with strong potential for therapeutic and regenerative medicine applications.

Indexed as

CRISPR-Cas SystemsCyclodextrinsGene EditingNanostructuresRibonucleoproteinsAnimalsCHO CellsCricetulusGreen Fluorescent ProteinsCyclodextrinsGreen Fluorescent ProteinsRibonucleoproteinsCHO cellsCRISPR-Casgenome editinghomology-directed repairnano delivery systemnanoparticlesribonucleoproteins

Identifiers

PMID41226719
PMCPMC12608112

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.